Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Umbilical cord blood transplantation improved the boy's symptoms despite complications.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

BST2 protein and certain T cells increase in early alopecia areata.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.